Reply to: Comments on "Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study)".

Saved in:
Bibliographic Details
Title: Reply to: Comments on "Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study)".
Authors: Molina-Cerrillo J; Department of Medical Oncology, Hospital Ramón y Cajal, Madrid, Spain.; ARON Research Foundation ETS, Macerata, Italy., Roviello G; ARON Research Foundation ETS, Macerata, Italy.; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Florence, Italy., Fiala O; ARON Research Foundation ETS, Macerata, Italy.; Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Taha T; ARON Research Foundation ETS, Macerata, Italy.; Royal Marsden NHS Foundation Trust, London, UK., Buti S; ARON Research Foundation ETS, Macerata, Italy.; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.; Department of Medicine and Surgery, University of Parma, Parma, Italy., Rizzo M; ARON Research Foundation ETS, Macerata, Italy.; Medical Oncology Unit, Azienda Ospedaliera Universitaria Consorziale Policlinico di Bari, Bari, Italy., Massari F; ARON Research Foundation ETS, Macerata, Italy.; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy., Monteiro FSM; ARON Research Foundation ETS, Macerata, Italy.; Oncology and Hematology Department, Hospital Sírio Libanês, Brasília, Brazil., Santoni M; ARON Research Foundation ETS, Macerata, Italy.; Medical Oncology Unit, Macerata Hospital, Macerata, Italy.
Source: International journal of cancer [Int J Cancer] 2026 Apr 01; Vol. 158 (7), pp. 1992-1994. Date of Electronic Publication: 2025 Dec 16.
Publication Type: Letter
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1097-0215
DOI:10.1002/ijc.70289